Ophthalmic

Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma, S.L. to Advance Its Dry Eye Program

Retrieved on: 
Monday, November 18, 2019
Pharmaceutical, Health, Optical, Organ systems, Dry eye syndrome, RTT, Ophthalmology, Ophthalmic, TRPM8, AVX, Avizorex Pharma, S.L., Aerie Pharmaceuticals, Inc.

(AVX Pharma or AVX), a Spanish ophthalmic pharmaceutical company developing therapeutics for the treatment of dry eye disease.

Key Points: 
  • (AVX Pharma or AVX), a Spanish ophthalmic pharmaceutical company developing therapeutics for the treatment of dry eye disease.
  • AVX completed a Phase 2a study in dry eye subjects earlier this year with its lead product candidate, AVX-012.
  • By stimulating these processes in a physiological manner, TRPM8 agonists have the potential to restore tear film stability and reduce discomfort in patients with dry eye.
  • This acquisition bolsters our pipeline with a clinical-stage dry eye product candidate, and we are excited to expand our footprint in ophthalmology.

Global Ophthalmic Viscoelastic Devices Market to Surpass US$ 1642.65 Million By 2027

Retrieved on: 
Thursday, November 7, 2019
General Health, Surgery, Medical devices, Health, Optical, Non-Newtonian fluids, Organ transplantation, Viscoelasticity, Ophthalmic, Physical sciences, Matter, Chemistry

Key Trends and Analysis of the Global Ophthalmic Viscoelastic Devices Market:

Key Points: 
  • Key Trends and Analysis of the Global Ophthalmic Viscoelastic Devices Market:
    Increasing number of corneal transplantation surgeries is expected to drive demand for ophthalmic viscoelastic devices .
  • Thus, such rising number of corneal transplant surgeries is expected to drive the growth of ophthalmic viscoelastic devices market.
  • The global ophthalmic viscoelastic devices market is projected to witness CAGR of 10.2% over the forecast period (2019 2027) owing to new product developments.
  • Global Ophthalmic Viscoelastic Devices Market, By Product Type:
    Global Ophthalmic Viscoelastic Devices Market, By Application:

Ophthalmic Sutures Market Worth $532.8 Million By 2026 | CAGR 6.4%: Grand View Research, Inc.

Retrieved on: 
Wednesday, November 6, 2019
Ophthalmic, Ophthalmology

According to the American Society of Ophthalmology, cataract alone affected over 24.4 million Americans aged 40 or more in 2016.

Key Points: 
  • According to the American Society of Ophthalmology, cataract alone affected over 24.4 million Americans aged 40 or more in 2016.
  • According WHO, it is estimated that around 1.3 million people live with some form of vision impairment currently.
  • Thus, with increasing number of outpatient surgeries, the ophthalmic sutures market is expected to witness lucrative growth over the forecast period.
  • Grand View Research has segmented the global ophthalmic sutures market based on type, absorption capacity, application, end use, and region:
    Ophthalmic Sutures Type Outlook (Revenue, USD Million, 2015 - 2026)
    Ophthalmic Sutures Absorption Capacity Outlook (Revenue, USD Million, 2015 - 2026)
    Ophthalmic Sutures Application Outlook (Revenue, USD Million, 2015 - 2026)

Ophthalmic Sutures Market Worth $532.8 Million By 2026 | CAGR 6.4%: Grand View Research, Inc.

Retrieved on: 
Wednesday, November 6, 2019
Ophthalmic, Ophthalmology

According to the American Society of Ophthalmology, cataract alone affected over 24.4 million Americans aged 40 or more in 2016.

Key Points: 
  • According to the American Society of Ophthalmology, cataract alone affected over 24.4 million Americans aged 40 or more in 2016.
  • According WHO, it is estimated that around 1.3 million people live with some form of vision impairment currently.
  • Thus, with increasing number of outpatient surgeries, the ophthalmic sutures market is expected to witness lucrative growth over the forecast period.
  • Grand View Research has segmented the global ophthalmic sutures market based on type, absorption capacity, application, end use, and region:
    Ophthalmic Sutures Type Outlook (Revenue, USD Million, 2015 - 2026)
    Ophthalmic Sutures Absorption Capacity Outlook (Revenue, USD Million, 2015 - 2026)
    Ophthalmic Sutures Application Outlook (Revenue, USD Million, 2015 - 2026)

Veatch Ophthalmic Instruments Now an Authorized Distributor of Haag-Streit Octopus Perimeters and Lenstar Biometry Devices

Retrieved on: 
Tuesday, October 22, 2019
Veatch, Ophthalmic, Streit

"Haag-Streit shares our commitment to providing state-of-the-art equipment for today's practitioners," said Kyna Veatch, president of Veatch Ophthalmic Instruments.

Key Points: 
  • "Haag-Streit shares our commitment to providing state-of-the-art equipment for today's practitioners," said Kyna Veatch, president of Veatch Ophthalmic Instruments.
  • A new standard in kinetic and static perimetry, Haag-Streit Octopus perimeters are the fastest, most efficient, and most accurate perimeters on the market.
  • Becoming an authorized nationwide distributor of Haag-Streit Octopus and Lenstar products allows Veatch to offer even more industry-leading technology and equipment to its valued customers.
  • Veatch Ophthalmic Instruments is a leading provider of ophthalmic equipment, supplies, and service.

CVP welcomes Cincinnati-based Apex Eye to its growing network of premier ophthalmology practices

Retrieved on: 
Friday, October 18, 2019
Ophthalmology, Ophthalmic, Optometry

CINCINNATI, Oct. 18, 2019 /PRNewswire/ --Apex Eye has joined CVP, the premier national ophthalmology management services organization in the nation.

Key Points: 
  • CINCINNATI, Oct. 18, 2019 /PRNewswire/ --Apex Eye has joined CVP, the premier national ophthalmology management services organization in the nation.
  • The new relationship aligns Apex Eye with the Cincinnati Eye Institute, a world-class center for ophthalmic care and the founding practice of CVP.
  • In turn, CVP will enable Apex Eye to drive growth in partnership with a network of leading ophthalmologists."
  • "Our alignment with CVP and the Cincinnati Eye Institute, equips Apex Eye to pursue visionary opportunities for eye care while defining a next-generation patient care experience."

Washington DC Ophthalmology Practice Enters Strategic Partnership With Eyecare Services Partners and Eye Doctors of Washington

Retrieved on: 
Thursday, October 17, 2019
Health, Optical, Optometry, Ophthalmic

Howard Jacobson, MD (Jacobson), a highly respected ophthalmic practice in Washington D.C., has entered into a strategic partnership with an affiliate of Eyecare Services Partners Management, LLC (ESP), the leading national provider of integrated eye care services, effective October 10, 2019.

Key Points: 
  • Howard Jacobson, MD (Jacobson), a highly respected ophthalmic practice in Washington D.C., has entered into a strategic partnership with an affiliate of Eyecare Services Partners Management, LLC (ESP), the leading national provider of integrated eye care services, effective October 10, 2019.
  • This is ESPs fourth transaction completed in the last 120 days as ESP continues to build on its leadership in comprehensive and integrated eye care services.
  • Jacobson is a non-surgical ophthalmic practice serving patients from its prime downtown Washington D.C. location.
  • It will become a strategic satellite office for ESPs nearby Eye Doctors of Washington (EDOW).

Glauconix Biosciences Announces Appointment of Robert Dempsey to Board of Directors

Retrieved on: 
Friday, October 11, 2019
Ophthalmic, Dempsey, Humans

Robert Dempsey joined Shire in 2014 and was the Group Vice President and Head of the Global Ophthalmology Franchise.

Key Points: 
  • Robert Dempsey joined Shire in 2014 and was the Group Vice President and Head of the Global Ophthalmology Franchise.
  • Mr. Robert Dempsey is joining Glauconix Biosciences' Board of Directors consisting of, Dr. Barbara Wirostko, Mr. Richard Frederick, Dr. Karen Torrejon and Dr. Chris Rocchio.
  • Mr. Richard Frederick, Co-Founder and Managing Director for Eastern NY angels (ENYA) and Glauconix Board Member remarks, "We are delighted that Bob has agreed to join our board.
  • Glauconix Biosciences is a leading developer of ophthalmic ex-vivo dynamic 3D human tissue models for accelerating therapeutic innovation and drug discovery.

Vantage EyeCare, LLC at 2019 American Academy of Ophthalmology Annual Meeting

Retrieved on: 
Thursday, October 10, 2019
Ophthalmology, Ophthalmic

PHILADELPHIA, Oct. 10, 2019 /PRNewswire/ -- The physicians and surgeons of Vantage EyeCare, LLC will be out in force at the American Academy of Ophthalmology's Annual Meeting in San Francisco, October 11 15, 2019, sharing their expertise and learning from their peers.

Key Points: 
  • PHILADELPHIA, Oct. 10, 2019 /PRNewswire/ -- The physicians and surgeons of Vantage EyeCare, LLC will be out in force at the American Academy of Ophthalmology's Annual Meeting in San Francisco, October 11 15, 2019, sharing their expertise and learning from their peers.
  • They join 16,000 ophthalmic professionals for the world's largest ophthalmic congress.
  • "Vantage EyeCare physicians are thought leaders, innovators, and national experts in their fields," says Julia Lee, CEO.
  • Additionally, as the largest ophthalmology practice in the country entirely physician-owned and operated, there continues to be great interest in our business model," explains Ms. Lee.

Ophthalmic Perimeters Market by End-users, Product, and Geography - Global Forecast and Analysis 2019-2023

Retrieved on: 
Monday, September 16, 2019
Ophthalmic, Ophthalmology

This ophthalmic perimeters market analysis considers sales from the static, combination, and kinetic segments to hospitals, ophthalmology clinics, and other end-users.

Key Points: 
  • This ophthalmic perimeters market analysis considers sales from the static, combination, and kinetic segments to hospitals, ophthalmology clinics, and other end-users.
  • Also, our global ophthalmic perimeters report has observed market growth factors such as the increasing prevalence of eye diseases, initiatives to increase awareness about eye care and eye diseases, and availability of refurbished ophthalmic perimeters.
  • These factors will contribute to the growth of the global ophthalmic perimeters market.
  • Also, the ophthalmic perimeters market analysis report includes information on upcoming trends and challenges that will influence market growth.